BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 182 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,023,272 | +33.9% | 152,570 | -12.7% | 0.00% | 0.0% |
| Q2 2023 | $3,004,513 | +113.9% | 174,681 | +106.1% | 0.00% | 0.0% |
| Q1 2023 | $1,404,956 | -48.8% | 84,738 | -76.5% | 0.00% | 0.0% |
| Q4 2022 | $2,742,270 | +3016.2% | 359,878 | +3983.5% | 0.00% | – |
| Q3 2022 | $88,000 | -95.6% | 8,813 | -96.0% | 0.00% | -100.0% |
| Q2 2022 | $2,008,000 | -55.2% | 221,077 | -50.0% | 0.00% | 0.0% |
| Q1 2022 | $4,487,000 | +266.3% | 442,040 | +502.3% | 0.00% | – |
| Q4 2021 | $1,225,000 | -76.8% | 73,387 | -34.9% | 0.00% | -100.0% |
| Q3 2021 | $5,283,000 | +296.3% | 112,725 | +415.3% | 0.00% | – |
| Q2 2021 | $1,333,000 | +62.2% | 21,875 | +64.0% | 0.00% | – |
| Q1 2021 | $822,000 | -39.5% | 13,341 | -30.2% | 0.00% | – |
| Q4 2020 | $1,359,000 | +98.1% | 19,118 | +4.5% | 0.00% | – |
| Q3 2020 | $686,000 | +8.7% | 18,295 | -5.4% | 0.00% | – |
| Q2 2020 | $631,000 | +36.6% | 19,344 | +21.5% | 0.00% | – |
| Q1 2020 | $462,000 | -26.9% | 15,920 | -11.8% | 0.00% | – |
| Q4 2019 | $632,000 | -12.6% | 18,041 | -46.5% | 0.00% | – |
| Q3 2019 | $723,000 | +4418.8% | 33,699 | +5516.5% | 0.00% | – |
| Q2 2019 | $16,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
| Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
| Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
| Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
| M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
| VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
| BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
| Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
| SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |